775 related articles for article (PubMed ID: 33604759)
21. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
Colombo N; Creutzberg C; Amant F; Bosse T; González-Martín A; Ledermann J; Marth C; Nout R; Querleu D; Mirza MR; Sessa C;
Ann Oncol; 2016 Jan; 27(1):16-41. PubMed ID: 26634381
[TBL] [Abstract][Full Text] [Related]
22. Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.
Imboden S; Nastic D; Ghaderi M; Rydberg F; Siegenthaler F; Mueller MD; Rau TT; Epstein E; Carlson JW
Gynecol Oncol; 2021 Aug; 162(2):394-400. PubMed ID: 34127276
[TBL] [Abstract][Full Text] [Related]
23. European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma.
Concin N; Planchamp F; Abu-Rustum NR; Ataseven B; Cibula D; Fagotti A; Fotopoulou C; Knapp P; Marth C; Morice P; Querleu D; Sehouli J; Stepanyan A; Taskiran C; Vergote I; Wimberger P; Zapardiel I; Persson J
Int J Gynecol Cancer; 2021 Dec; 31(12):1508-1529. PubMed ID: 34795020
[TBL] [Abstract][Full Text] [Related]
24. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery.
Querleu D; Planchamp F; Chiva L; Fotopoulou C; Barton D; Cibula D; Aletti G; Carinelli S; Creutzberg C; Davidson B; Harter P; Lundvall L; Marth C; Morice P; Rafii A; Ray-Coquard I; Rockall A; Sessa C; van der Zee A; Vergote I; duBois A
Int J Gynecol Cancer; 2017 Sep; 27(7):1534-1542. PubMed ID: 30814245
[TBL] [Abstract][Full Text] [Related]
25. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
[TBL] [Abstract][Full Text] [Related]
26. European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer.
Oonk MHM; Planchamp F; Baldwin P; Bidzinski M; Brännström M; Landoni F; Mahner S; Mahantshetty U; Mirza M; Petersen C; Querleu D; Regauer S; Rob L; Rouzier R; Ulrikh E; van der Velden J; Vergote I; Woelber L; van der Zee AGJ
Int J Gynecol Cancer; 2017 May; 27(4):832-837. PubMed ID: 28441255
[TBL] [Abstract][Full Text] [Related]
27. An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile app.
Gaillard T; Schwameis R; Laas-Faron E; Eisenberg-Nissim T; Matias-Guiu X; Creutzberg CL; Ledermann J; Planchamp F; Concin N
Int J Gynecol Cancer; 2023 Aug; 33(8):1181-1184. PubMed ID: 37460218
[TBL] [Abstract][Full Text] [Related]
28. Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
Nero C; Pasciuto T; Cappuccio S; Corrado G; Pelligra S; Zannoni GF; Santoro A; Piermattei A; Minucci A; Lorusso D; Fanfani F; Scambia G
Cancer; 2022 Aug; 128(15):2898-2907. PubMed ID: 35617463
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer.
Vrede SW; van Weelden WJ; Visser NCM; Bulten J; van der Putten LJM; van de Vijver K; Santacana M; Colas E; Gil-Moreno A; Moiola CP; Mancebo G; Krakstad C; Trovik J; Haldorsen IS; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; van der Wurff AA; Matias-Guiu X; Amant F; ; Snijders MPLM; Küsters-Vandevelde HVN; Reijnen C; Pijnenborg JMA
Gynecol Oncol; 2021 Jun; 161(3):787-794. PubMed ID: 33858677
[TBL] [Abstract][Full Text] [Related]
30. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
31. Pocket memo based on the ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma: definition of prognostic risk groups.
Daix M; Gladieff L; Martinez A; Ferron G; Angeles MA
Int J Gynecol Cancer; 2021 Dec; 31(12):1615-1616. PubMed ID: 34645685
[No Abstract] [Full Text] [Related]
32. [Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)].
Querleu D; Darai E; Lecuru F; Rafii A; Chereau E; Collinet P; Crochet P; Marret H; Mery E; Thomas L; Villefranque V; Floquet A; Planchamp F
Gynecol Obstet Fertil Senol; 2017 Dec; 45(12):715-725. PubMed ID: 29132772
[TBL] [Abstract][Full Text] [Related]
33. Gynecologic Oncologist Perspective About ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer.
Dursun P; Ayhan A
Int J Gynecol Cancer; 2017 May; 27(4):826-831. PubMed ID: 28441254
[TBL] [Abstract][Full Text] [Related]
34. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
[TBL] [Abstract][Full Text] [Related]
35. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
36. [Application in France of the 2021 European recommendations on endometrial cancer].
Deluche E; Marti C; Jochum F; Bendifallah S; Azaïs H; Deidier J; Cockenpot V; Menoux I; Kissel M; Balaya V; Betrian S; Mathevet P; Chargari C; Gouy S; Genestie C; Uzan C; Devouassoux-Shisheboran M; Guyon F; Akladios C; Body N; Guani B;
Bull Cancer; 2023 Jan; 110(1):55-68. PubMed ID: 36462971
[TBL] [Abstract][Full Text] [Related]
37. [European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer].
Ballester M; Bendifallah S; Daraï E
Bull Cancer; 2017 Dec; 104(12):1032-1038. PubMed ID: 29173977
[TBL] [Abstract][Full Text] [Related]
38. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.
Colombo N; Sessa C; du Bois A; Ledermann J; McCluggage WG; McNeish I; Morice P; Pignata S; Ray-Coquard I; Vergote I; Baert T; Belaroussi I; Dashora A; Olbrecht S; Planchamp F; Querleu D;
Ann Oncol; 2019 May; 30(5):672-705. PubMed ID: 31046081
[TBL] [Abstract][Full Text] [Related]
39. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
van de Velde CJ; Boelens PG; Borras JM; Coebergh JW; Cervantes A; Blomqvist L; Beets-Tan RG; van den Broek CB; Brown G; Van Cutsem E; Espin E; Haustermans K; Glimelius B; Iversen LH; van Krieken JH; Marijnen CA; Henning G; Gore-Booth J; Meldolesi E; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten H; Schmoll HJ; Smith JJ; Tanis PJ; Taylor C; Wibe A; Wiggers T; Gambacorta MA; Aristei C; Valentini V
Eur J Cancer; 2014 Jan; 50(1):1.e1-1.e34. PubMed ID: 24183379
[TBL] [Abstract][Full Text] [Related]
40. Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.
Daix M; Angeles MA; Migliorelli F; Kakkos A; Martinez Gomez C; Delbecque K; Mery E; Tock S; Gabiache E; Decuypere M; Goffin F; Martinez A; Ferron G; Kridelka F
J Gynecol Oncol; 2021 Jul; 32(4):e48. PubMed ID: 33908709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
